Haven't asked Serum to take back 1 mn Covishield doses, says South Africa

South Africa plans to share AstraZeneca shots via African Union, says Anban Pillay, deputy director-general at the Department of Health

Covishield
Reuters
1 min read Last Updated : Feb 16 2021 | 4:33 PM IST
South Africa plans to share the 1 million AstraZeneca COVID-19 vaccine doses it received from the Serum Institute of India with other African countries via the African Union (AU), a senior health official said on Tuesday.

The country paused the rollout of the AstraZeneca vaccine this month, after preliminary trial data showed it offered minimal protection against mild to moderate illness from the country's dominant coronavirus variant.

It plans to start inoculating healthcare workers with Johnson & Johnson's vaccine as soon as this week in a research study.

"The doses are going to be shared with countries on the continent, ... via the AU," Anban Pillay, deputy director-general at the Department of Health, told Reuters.

He added that South Africa would look to recover money spent on the vaccine doses but was still finalising how to do that.
Pillay said a report in Indian newspaper The Economic Times that South Africa had asked the Serum Institute to take back the 1 million doses that arrived at the start of the month was not true.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Serum Institute of India

Next Story